Risk factors for status epilepticus in children with symptomatic epilepsy

被引:23
作者
Novak, G
Maytal, J
Alshansky, A
Ascher, C
机构
[1] Division of Neurology, Schneider Children's Hospital, New Hyde Park, NY
[2] Division of Neurology, Schneider Children's Hospital, New Hyde Park
关键词
D O I
10.1212/WNL.49.2.533
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to determine risk factors for status epilepticus (SE) in children with symptomatic epilepsy through a retrospective case-control study. Patients (44 children with a prior diagnosis of symptomatic epilepsy experiencing one or more episodes of SE between January 1, 1991, and June 1, 1995) were matched for age at follow-up to controls (88 children with symptomatic epilepsy without SE during that interval) and medical records were reviewed. Patients and controls did not differ in etiology or in age at epilepsy onset (1 year 5 months [SD, 2 years 3 months] versus 1 year 3 months [SD, 1 year 5 months]). Univariate analysis revealed significant associations between SE and several factors, including history of a first seizure as SE, partial epilepsy, partial seizures with secondary generalization, focal paroxysmal abnormalities and focal background abnormalities on EEG, and generalized abnormalities on neuroimaging. Groups did not differ in the proportion of patients on polypharmacy or with subtherapeutic serum antiepileptic drug levels, but there was a trend for greater use of phenobarbital in patients (57% versus 38%, odds ratio (OR) = 2.6, p = 0.057). With multiple logistic regression, four factors emerged as independent predictors of SE risk: focal background EEG abnormalities (OR = 6.51, p = 0.0005), partial seizures with secondary generalization (OR = 4.61, p = 0.0021), first seizure as SE (OR = 3.99, p = 0.034), and generalized abnormalities on neuroimaging (OR = 2.85, p = 0.034). These four factors are indicators of a higher risk of SE in children with symptomatic epilepsy.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 27 条
[1]   STATUS EPILEPTICUS - CAUSES, CLINICAL-FEATURES AND CONSEQUENCES IN 98 PATIENTS [J].
AMINOFF, MJ ;
SIMON, RP .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (05) :657-666
[2]  
[Anonymous], 1981, Epilepsia, V22, P489
[3]  
[Anonymous], 1993, EPILEPSIA, V34, P592
[4]   STATUS EPILEPTICUS AND ANTIEPILEPTIC MEDICATION LEVELS [J].
BARRY, E ;
HAUSER, WA .
NEUROLOGY, 1994, 44 (01) :47-50
[5]   Predictors of intractable epilepsy in childhood: A case-control study [J].
Berg, AT ;
Levy, SR ;
Novotny, EJ ;
Shinnar, S .
EPILEPSIA, 1996, 37 (01) :24-30
[6]   PHENYTOIN WITHDRAWAL AND SEIZURE FREQUENCY [J].
BROMFIELD, EB ;
DAMBROSIA, J ;
DEVINSKY, O ;
NICE, FJ ;
THEODORE, WH .
NEUROLOGY, 1989, 39 (07) :905-909
[7]  
CASCINO GD, 1995, EPILEPSIA, V36, P249
[8]  
*COMM CLASS TERM I, 1989, EPILEPSIA, V30, P268
[9]  
DELORENZO RJ, 1992, EPILEPSIA, V33, pS15
[10]  
DHUDAK N, 1993, NEUROLOGY S2, V43, pA198